Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in Amsterdam [Yahoo! Finance]
Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in Amsterdam
Femasys gains CE Mark approval for women's health products [Yahoo! Finance]
Femasys Inc. (NASDAQ: FEMY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Femasys Receives CE Mark Approval for Four of its Women's Health Products Clearing the Path for the Company to Begin Commercialization Efforts in Europe [Yahoo! Finance]